IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adviser Update

8 Aug 2006 14:45

Skyepharma PLC08 August 2006 For Immediate Release 8 August 2006 SkyePharma PLC Change of Auditor LONDON, UK, 8 August 2006 - SkyePharma PLC (LSE: SKP; NASDAQ:SKYE) announcesthat following completion of the audit of the Company's financial statements forthe year ended 31 December 2005 and the preparation and filing with the SEC ofits 2005 Annual Report on Form 20-F, PricewaterhouseCoopers LLP ("PwC") hasgiven notice of its resignation as auditor. In its resignation letter PwC statedthat: "Pursuant to Section 394 of the Companies Act 1985, we confirm that thereare no circumstances connected with our resignation which we consider should bebrought to the notice of the shareholders or creditors of Skyepharma PLC." SkyePharma's Audit Committee has invited tenders from certain qualified auditingfirms and the Company will make a further announcement in due course when a newauditor has been appointed. It is anticipated that the new auditor will beresponsible for reviewing the unaudited interim results for the six months ended30 June 2006, which are expected to be announced in late September 2006. PwC has been SkyePharma's auditor for the past ten years. PwC's resignationcoincides with the lead audit partner's required rotation after five years underthe Auditing Practices Board's Ethical Standards guidelines. For further information please contact: SkyePharma PLC +44 207 491 1777Peter Laing, Director of Corporate Communications +44 207 491 5124Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court / Rebecca Skye Dietrich About SkyePharma SkyePharma PLC develops pharmaceutical products benefiting from world-leadingdrug delivery technologies that provide easier-to-use and more effective drugformulations. There are now twelve approved products incorporating SkyePharma'stechnologies in the areas of oral, injectable, inhaled and topical delivery,supported by advanced solubilisation capabilities. For more information, visitwww.skyepharma.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Apr 20087:01 amRNSResearch Update
3rd Apr 200812:27 pmRNSShare Purchase Plan
27th Mar 20087:02 amRNSFinal Results
27th Mar 20087:01 amRNSBoard Change
12th Mar 20084:53 pmRNSHolding(s) in Company
10th Mar 20085:17 pmRNSHolding(s) in Company
3rd Mar 20083:00 pmRNSDirector/PDMR Shareholding
21st Feb 200812:19 pmRNSNotice of Results
8th Feb 20087:00 amRNSRe Agreement
5th Feb 20087:01 amRNSResearch Update
4th Feb 20081:06 pmRNSDirector Declaration
1st Feb 20085:20 pmRNSRe: Share Purchase Plan
1st Feb 200810:49 amRNSHolding(s) in Company
10th Jan 20085:34 pmRNSHolding(s) in Company
3rd Jan 20088:33 amRNSRegulatory Approval
2nd Jan 20084:11 pmRNSShare Purchase Plan
20th Dec 20077:01 amRNSRe Agreement
18th Dec 200711:37 amRNSDirector Declaration
18th Dec 20077:01 amRNSResearch Update
11th Dec 200711:31 amRNSHolding(s) in Company
10th Dec 20071:46 pmRNSRegulatory Application Update
5th Dec 200711:46 amRNSShare Purchase Plan
29th Nov 20077:01 amRNSBoard Change
27th Nov 20074:19 pmRNSHolding(s) in Company
23rd Nov 20072:45 pmRNSHolding(s) in Company
20th Nov 200712:40 pmRNSPiper Jaffray Conference
19th Nov 200711:15 amRNSHolding(s) in Company
13th Nov 20074:23 pmRNSDirector Declaration
5th Nov 20072:00 pmRNSProduct Update
2nd Nov 20072:55 pmRNSDirector/PDMR Shareholding
2nd Nov 20077:00 amRNSResearch Update
29th Oct 20072:28 pmRNSHolding(s) in Company
23rd Oct 20071:56 pmRNSPaxil Settlement
19th Oct 200711:09 amRNSHolding(s) in Company
9th Oct 20072:42 pmRNSNon-Executive Chairman
8th Oct 20077:01 amRNSChange of Marketing Partner
2nd Oct 20073:52 pmRNSRe: Share Purchase Plan
27th Sep 20071:00 pmRNSProduct Launch
25th Sep 20074:13 pmRNSSachs Biotech Conference
20th Sep 20077:03 amRNSInterim Results
19th Sep 20074:37 pmRNSUBS Life Sciences Conference
11th Sep 20077:03 amRNSResearch Update
7th Sep 20079:00 amRNSAppointment of Adviser
6th Sep 20074:56 pmRNSNotice of Results
6th Sep 20073:09 pmRNSShare Purchase Plan
5th Sep 20077:02 amRNSRegulatory Approval
14th Aug 20074:51 pmRNSHolding(s) in Company
6th Aug 20077:01 amRNSResearch Update
2nd Aug 20074:01 pmRNSShare Purchase Plan
17th Jul 200712:01 pmRNSAGM Resolutions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.